II
Inspire Investing Portfolio holdings
AUM
$918M
1-Year Return
14.89%
This Quarter Return
-0.57%
1 Year Return
+14.89%
3 Year Return
+68.03%
5 Year Return
+142.65%
10 Year Return
–
AUM
$894M
AUM Growth
-$83.9M
(-8.6%)
Cap. Flow
-$48.2M
Cap. Flow
% of AUM
-5.39%
Top 10 Holdings %
Top 10 Hldgs %
15.04%
Holding
873
New
46
Increased
345
Reduced
419
Closed
49
Top Buys
| 1 |
Pegasystems
PEGA
|
+$1.78M |
| 2 |
Trane Technologies
TT
|
+$1.7M |
| 3 |
Arista Networks
ANET
|
+$1.6M |
| 4 |
InterDigital
IDCC
|
+$1.58M |
| 5 |
Inspire International ETF
WWJD
|
+$1.26M |
Top Sells
| 1 |
Super Micro Computer
SMCI
|
+$30.8M |
| 2 |
Inspire Corporate Bond ETF
IBD
|
+$6.59M |
| 3 |
HealthEquity
HQY
|
+$1.64M |
| 4 |
First Citizens BancShares
FCNCA
|
+$1.58M |
| 5 |
Garmin
GRMN
|
+$1.55M |
Sector Composition
| 1 | Technology | 21.27% |
| 2 | Industrials | 18.75% |
| 3 | Financials | 11.79% |
| 4 | Healthcare | 10.41% |
| 5 | Real Estate | 8.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
Angi Inc
ANGI
$803M
| $414K | 0.05% |
24,940
-21,270
| -46% | -$353K |
|
352
Geron
GERN
$868M
| $414K | 0.05% |
116,860
-42,894
| -27% | -$152K |
|
353
Agilon Health
AGL
$477M
| $413K | 0.05% |
217,550
+112,241
| +107% | +$213K |
|
354
PTC Therapeutics
PTCT
$4.52B
| $412K | 0.05% |
9,127
-1,912
| -17% | -$86.3K |
|
355
UFP Technologies
UFPT
$1.59B
| $411K | 0.05% |
1,681
+387
| +30% | +$94.6K |
|
356
Watts Water Technologies
WTS
$9.47B
| $411K | 0.05% |
2,020
-23
| -1% | -$4.68K |
|
|
ITCI
357
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $410K | 0.05% |
4,915
-691
| -12% | -$57.7K |
|
358
Valmont Industries
VMI
$7.49B
| $409K | 0.05% |
1,334
-116
| -8% | -$35.6K |
|
|
SAGE
359
DELISTED
Sage Therapeutics
SAGE
| $409K | 0.05% |
75,313
+17,541
| +30% | +$95.2K |
|
360
Energy Recovery
ERII
$776M
| $409K | 0.05% |
27,801
+3,594
| +15% | +$52.8K |
|
361
American States Water
AWR
$2.83B
| $409K | 0.05% |
5,257
+206
| +4% | +$16K |
|
362
Franklin Electric
FELE
$4.34B
| $409K | 0.05% |
4,192
+164
| +4% | +$16K |
|
363
Gorman-Rupp
GRC
$1.13B
| $408K | 0.05% |
10,755
-145
| -1% | -$5.5K |
|
364
Glaukos
GKOS
$5.21B
| $408K | 0.05% |
2,719
-474
| -15% | -$71.1K |
|
365
Protagonist Therapeutics
PTGX
$3.63B
| $407K | 0.05% |
10,555
-25,959
| -71% | -$1M |
|
366
Syndax Pharmaceuticals
SNDX
$1.37B
| $407K | 0.05% |
30,792
+9,484
| +45% | +$125K |
|
367
Agios Pharmaceuticals
AGIO
$2.1B
| $407K | 0.05% |
12,384
+3,156
| +34% | +$104K |
|
368
Biohaven
BHVN
$1.53B
| $407K | 0.05% |
10,895
+2,698
| +33% | +$101K |
|
369
ONE Gas
OGS
$4.47B
| $407K | 0.05% |
5,872
-4,228
| -42% | -$293K |
|
|
ALX
370
Alexander's
ALX
$1.2B
| $407K | 0.05% |
2,032
+353
| +21% | +$70.6K |
|
371
Spire
SR
$4.47B
| $407K | 0.05% |
5,993
-4,852
| -45% | -$329K |
|
372
Amicus Therapeutics
FOLD
$2.46B
| $406K | 0.05% |
43,151
-27,522
| -39% | -$259K |
|
373
Southwest Gas
SWX
$5.58B
| $406K | 0.05% |
5,748
-4,099
| -42% | -$290K |
|
374
Forward Air
FWRD
$913M
| $406K | 0.05% |
12,601
+1,088
| +9% | +$35.1K |
|
375
Acadia Healthcare
ACHC
$2.15B
| $406K | 0.05% |
10,249
+3,602
| +54% | +$143K |
|